68 records, the earliest from 6 Aug 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
68 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Purpose | Notes |
|---|---|---|
| 12 Aug 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 27 May 2026 | Financial Results/Dividend/Other business matters | To consider and approve the audited financial results for the period ended March 31, 2026, dividend and other business matters |
| 11 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 12 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2025 and other business matters |
| 11 Aug 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2025 and other business matters |
| 29 May 2025 | Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2025, dividend and other business matters |
| 13 Feb 2025 | Financial Results/Fund Raising | To consider and approve the financial results for the period ended December 31, 2024 and Fund Raising |
| 14 Nov 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
| 9 Sep 2024 | Other business matters | 1.Allotment of Equity Shares to the employees of the Company upon conversion of stock options vested on them.2. To consider expanding its manufacturing presence to meet the growing demand for Active Pharma Ingredients ( API's)3.Any other matter incidental to the business operations and ensuing Annual General Meeting of the Company. |
| 12 Aug 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
